| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-11 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-09 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-08 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.26 | 9e-07 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |